While almost 70 percent of the Philippine population have completed their primary COVID-19 doses, not even half of that number has gotten jabbed for both first and second booster shots.
How do we encourage more people to get boosted against COVID-19? Do we need to get booster shots in the first place? How urgent is it for us to get boosted? Do we have enough vaccines to cover the vulnerable for first and second boosters?
This July 8, from 12nn to 2 pm, the University of the Philippines (UP), in partnership with UP Manila National Institutes of Health (UP-NIH), National Telehealth Center (NTC), and cooperation with UP Philippine General Hospital (UP-PGH), invite you to join the fight against C.O.V.I.D—current COVID-19 problems, other outbreaks, viruses, infections, and disasters.
This week’s episode will discuss the science behind boosters for COVID-19 and the process used for coming up with recommendations by the Health Technology Assessment Council (HTAC). The webinar will revisit this new group organized under the Universal Health Care Law, its role and purpose, and how it has worked with other agencies during this pandemic.
Dr. Marita V. Tolentino-Reyes, Former UP Manila Chancellor and current head of HTAC, will present an overview of boosters and their role in the waning immunity for COVID-19.
Dr. Limuel Anthony B. Abrogena, Chair of the Subcommittee on Prevention and Promotive Health Services at HTAC, will discuss their recommendations for different groups and all the processes.
Lastly, Dr. Anna Melissa S. Guerrero, Department of Health (DOH) Director for Regulations, will discuss the operational challenges and possible solutions for bringing all localities to higher vaccination levels.
The webinar will end with the synthesis of Dr. Stella Marie L. Jose, Deputy Director for Health Operations at UP-PGH.
The award-winning UP “Stop COVID Deaths” Webinar Series is the Philippines’ first and only frontline-focused medical webinar series. It pioneered the discussion, dissemination, and adoption of knowledge on COVID-19 treatment and management. Follow our accounts to stay connected with your credible online community.